Form 4: Acadia Pharmaceuticals Executive Mark Schneyer Reports Stock Transactions
SEC Form 4 Filing
Mark Schneyer, EVP and CFO of Acadia Pharmaceuticals, reports the vesting of restricted stock units and subsequent sale of shares to cover withholding taxes.
Summary
- On May 1, 2024, Mark Schneyer vested 6,814 restricted stock units, each representing a contingent right to receive one share of Acadia Pharmaceuticals common stock.
- These restricted stock units vest in four equal annual installments beginning May 1, 2024.
- On May 2, 2024, Schneyer sold 3,503 shares of common stock at a weighted average price of $16.94, with prices ranging from $16.94 to $17.03.
- The sales were made to cover withholding taxes and tax-related items imposed by Acadia Pharmaceuticals in connection with the vesting of restricted stock units.
- Following these transactions, Schneyer directly owns 32,053 shares of Acadia Pharmaceuticals common stock and 20,445 restricted stock units.
Sentiment
Score: 5
Explanation: The document reflects routine transactions related to executive compensation and tax obligations, with no indication of significant positive or negative sentiment.
Industry Context
Form 4 filings are standard disclosures required by the SEC for company insiders, providing transparency into their transactions in the company's stock. This filing indicates routine transactions related to executive compensation and tax obligations.
Stakeholder Impact
- The transactions have a minimal impact on shareholders, as they are related to executive compensation and tax obligations.
Key Dates
| Date | Description |
|---|---|
| 05/01/2024 | Date of earliest transaction; vesting of restricted stock units. |
| 05/02/2024 | Date of stock sale to cover withholding taxes. |
| 05/03/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.